Bitpanda makes it easy for you to invest in Evotec from as little as €1. Invest 24/7 with zero commissions and tight spreads.
*Bitpanda Stocks are contracts replicating an underlying stock or ETF.
Create a Bitpanda account and confirm your email address.
Confirm your identity with one of our trusted verification partners and deposit funds.
You’re all set! Start investing with Bitpanda Stocks in Evotec and over 2,500 other digital assets.
Evotec SE engages in the discovery and development of new drugs for pharmaceutical and biotechnology companies. It operates through the following segments: EVT Execute and EVT Innovate. The EVT Execute segment provides stand-alone or integrated drug discovery solutions for collaborators' targets and programmers on a typical fee-for-service basis or through a variety of commercial structures, which may include performance-based components, such as milestones and royalties. The EVT Innovate develops drug discovery projects, assets and platforms, both internally or through academic collaborations. The company was founded by Manfred Eigen, Karsten Henco, Ulrich Aldag, Freimut Leidenberger, Heinrich Maria Schulte, Rudolf Rigler, and Charles Weissmann on December 8, 1993 and is headquartered in Hamburg, Germany.